209 related articles for article (PubMed ID: 18761421)
1. Monocyte chemoattractant protein-1: a key mediator in inflammatory processes.
Melgarejo E; Medina MA; Sánchez-Jiménez F; Urdiales JL
Int J Biochem Cell Biol; 2009 May; 41(5):998-1001. PubMed ID: 18761421
[TBL] [Abstract][Full Text] [Related]
2. Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies.
Daly C; Rollins BJ
Microcirculation; 2003 Jun; 10(3-4):247-57. PubMed ID: 12851642
[TBL] [Abstract][Full Text] [Related]
3. Monocyte chemoattractant protein-1 immunoreactivity in sensory ganglia and hindpaw after adjuvant injection.
Jeon SM; Lee KM; Park ES; Jeon YH; Cho HJ
Neuroreport; 2008 Jan; 19(2):183-6. PubMed ID: 18185105
[TBL] [Abstract][Full Text] [Related]
4. Monocyte chemoattractant protein (MCP-1) is expressed in human cardiac cells and is differentially regulated by inflammatory mediators and hypoxia.
Hohensinner PJ; Kaun C; Rychli K; Ben-Tal Cohen E; Kastl SP; Demyanets S; Pfaffenberger S; Speidl WS; Rega G; Ullrich R; Maurer G; Huber K; Wojta J
FEBS Lett; 2006 Jun; 580(14):3532-8. PubMed ID: 16730716
[TBL] [Abstract][Full Text] [Related]
5. Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease.
Rollins BJ
Mol Med Today; 1996 May; 2(5):198-204. PubMed ID: 8796888
[TBL] [Abstract][Full Text] [Related]
6. CCL2 DNA vaccine to treat renal disease.
Watson D; Zheng G; Wu H; Wang YM; Wang Y; Harris DC; Alexander SI
Int J Biochem Cell Biol; 2009 Apr; 41(4):729-32. PubMed ID: 18768165
[TBL] [Abstract][Full Text] [Related]
7. Structure activity relationships of monocyte chemoattractant proteins in complex with a blocking antibody.
Reid C; Rushe M; Jarpe M; van Vlijmen H; Dolinski B; Qian F; Cachero TG; Cuervo H; Yanachkova M; Nwankwo C; Wang X; Etienne N; Garber E; Bailly V; de Fougerolles A; Boriack-Sjodin PA
Protein Eng Des Sel; 2006 Jul; 19(7):317-24. PubMed ID: 16682434
[TBL] [Abstract][Full Text] [Related]
8. Role of osteopontin in induction of monocyte chemoattractant protein 1 and macrophage inflammatory protein 1beta through the NF-kappaB and MAPK pathways in rheumatoid arthritis.
Zheng W; Li R; Pan H; He D; Xu R; Guo TB; Guo Y; Zhang JZ
Arthritis Rheum; 2009 Jul; 60(7):1957-65. PubMed ID: 19565503
[TBL] [Abstract][Full Text] [Related]
9. Cysteinyl leukotrienes induce monocyte chemoattractant protein-1 in human monocyte/macrophages via mitogen-activated protein kinase and nuclear factor-kappaB pathways.
Hashimoto K; Ichiyama T; Hasegawa M; Hasegawa S; Matsubara T; Furukawa S
Int Arch Allergy Immunol; 2009; 149(3):275-82. PubMed ID: 19218821
[TBL] [Abstract][Full Text] [Related]
10. Recent developments in CCR2 antagonists.
Xia M; Sui Z
Expert Opin Ther Pat; 2009 Mar; 19(3):295-303. PubMed ID: 19441905
[TBL] [Abstract][Full Text] [Related]
11. Expression of monocyte chemoattractant protein-1 in the cerebral artery after experimental subarachnoid hemorrhage.
Lu H; Shi JX; Chen HL; Hang CH; Wang HD; Yin HX
Brain Res; 2009 Mar; 1262():73-80. PubMed ID: 19401162
[TBL] [Abstract][Full Text] [Related]
12. Generation, characterization and biological activity of CCL2 (MCP-1/JE) and CCL12 (MCP-5) specific antibodies.
Tsui P; Das A; Whitaker B; Tornetta M; Stowell N; Kesavan P; Kaiser E; Lacy ER; Yan L; Snyder LA; Sweet R
Hum Antibodies; 2007; 16(3-4):117-25. PubMed ID: 18334747
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of CCL2 (MCP-1) and CCL2 mRNA by substance P in LAD2 human mast cells.
Castellani ML; Vecchiet J; Salini V; Conti P; Theoharides TC; Caraffa A; Antinolfi P; Teté S; Ciampoli C; Cuccurullo C; Cerulli G; Felaco M; Boscolo P
Transl Res; 2009 Jul; 154(1):27-33. PubMed ID: 19524871
[TBL] [Abstract][Full Text] [Related]
14. Monocyte chemoattractant protein-1 (MCP-1): an overview.
Deshmane SL; Kremlev S; Amini S; Sawaya BE
J Interferon Cytokine Res; 2009 Jun; 29(6):313-26. PubMed ID: 19441883
[TBL] [Abstract][Full Text] [Related]
15. Synthetic, site-specific biotinylated analogs of human MCP-1.
Kruszynski M; Tsui P; Stowell N; Luo J; Nemeth JF; Das AM; Sweet R; Heavner GA
J Pept Sci; 2006 May; 12(5):354-60. PubMed ID: 16285024
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of Interleukin-8 and monocyte chemoattractant protein-1 expression within the abdominal aortic aneurysm and their association with mural inflammation.
Middleton RK; Bown MJ; Lloyd GM; Jones JL; London NJ; Sayers RD
Eur J Vasc Endovasc Surg; 2009 Jan; 37(1):46-55. PubMed ID: 19008128
[TBL] [Abstract][Full Text] [Related]
17. Blocking mast cell-mediated type I hypersensitivity in experimental allergic conjunctivitis by monocyte chemoattractant protein-1/CCR2.
Tominaga T; Miyazaki D; Sasaki S; Mihara S; Komatsu N; Yakura K; Inoue Y
Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5181-8. PubMed ID: 19553621
[TBL] [Abstract][Full Text] [Related]
18. Monocyte chemoattractant protein-1 in acute coronary syndromes: complex vicious interaction.
Amasyali B; Kose S; Kursaklioglu H; Barcin C; Kilic A
Int J Cardiol; 2009 Aug; 136(3):356-7. PubMed ID: 18684531
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory interaction between LIGHT and proteinase-activated receptor-2 in endothelial cells: potential role in atherogenesis.
Sandberg WJ; Halvorsen B; Yndestad A; Smith C; Otterdal K; Brosstad FR; Frøland SS; Olofsson PS; Damås JK; Gullestad L; Hansson GK; Oie E; Aukrust P
Circ Res; 2009 Jan; 104(1):60-8. PubMed ID: 19023130
[TBL] [Abstract][Full Text] [Related]
20. Ghrelin and obestatin modulate early atherogenic processes on cells: enhancement of monocyte adhesion and oxidized low-density lipoprotein binding.
Kellokoski E; Kunnari A; Jokela M; Mäkelä S; Kesäniemi YA; Hörkkö S
Metabolism; 2009 Nov; 58(11):1572-80. PubMed ID: 19608205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
